The P-glycoprotein multidrug transporter

General Pharmacology

Volumn 27, Issue 8, 1996, Pages 1283-1291

  Fardel, Olivier ^a,b   Lecureur, Valérie ^a   Guillouzo, André ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b Lab de Pharmacologie Moléc   (France)

Author keywords

anticancer drug; chemotherapy; MDR genes; multidrug resistance; P glycoprotein

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BEPRIDIL; CALCIUM CHANNEL BLOCKING AGENT; CALMODULIN INHIBITOR; DACTINOMYCIN; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; GLYCOPROTEIN P; HORMONE; IMMUNOSUPPRESSIVE AGENT; MITOXANTRONE; MULTIDRUG RESISTANCE REVERSING AGENT; NICARDIPINE; NIFEDIPINE; PACLITAXEL; QUINOLINE DERIVATIVE; RESERPINE; STEROID; SURFACTANT; TENIPOSIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERAPAMIL; VINBLASTINE; VINCRISTINE; XENOBIOTIC AGENT; YOHIMBINE;

CANCER; CELL LEVEL; CLINICAL TRIAL; DRUG TRANSPORT; GENE EXPRESSION; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REGULATORY MECHANISM; RELAPSE; REVIEW; RODENT; SOLID TUMOR; TREATMENT FAILURE;

ANIMALS; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION; GENES, MDR; HUMANS; MODELS, STRUCTURAL; NEOPLASMS; P-GLYCOPROTEIN;

EID: 0030561363     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00081-X     Document Type: Review

References (157)

1. Abraham E. H., Prat A. G., Gerweek L., Seneveraine T., Arceci R. J., Kramer R., Guidotti G. and Cantiello H. F. (1993) The multidrug resistance (mdr1) gene product functions as an ATP channel, Proc. Natl. Acad. Sci. USA 90, 312-316.
2. Ambudkar S. V., Lelong I. H., Zhang J., Cardarelli C. O., Gottesman M. M. and Pastan I. (1992) Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis. Proc. Natl. Acad. Sci. USA 89, 8472-8476.
3. Arao S., Suwa H., Mandai M., Tashiro H., Miyazaki K., Okamura H., Nomura H., Hiai H. and Fukumoto M. (1994) Expression of multidrug resistance gene and localization of P-glycoprotein in human primary ovarian cancer. Cancer Res. 54, 1355-1359.
4. Arceci R. J., Croop J. M., Horwitz S. B. and Housman D. (1988) The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus. Proc. Natl. Acad. Sci. USA 85, 4350-4354.
5. Arceci R. J., Baas F., Raponi R., Horwitz S. B., Housman D. and Croop J. M. (1990) Multidrug resistance gene expression is controlled by steroid hormones in the secretory epithelium of the uterus. Mol. Reprod. Dev. 25, 101-109.
6. Arceci R. J. (1993) Clinical significance of P-glycoprotein in multidrug resistance malignancies. Blood 81, 2215-2222.
7. Azzaria M., Schurr E. and Gros P. (1989) Discrete mutations introduced in the predicted nucleotide-binding sites of the mdr1 gene abolish its ability to confer multidrug resistance. Mol. Cell. Biol. 9, 5289-5297.
8. Bates S. E., Mickley L. A., Chen Y. N., Richert N., Rudick J., Biedler J. L. and Fojo A. T. (1989) Expression of a drug resistance gene in human neuroblastoma cellines: modulation by retinoic acid-induced differentiation. Mol. Cell. Biol. 9, 4337-4344.
9. Bates S. E., Currier S. J., Alvarez M. and Fojo A. T. (1992) Modulation of P-glycoprotein phosphorylation and drug transport by sodium butyrate. Biochemistry 31, 6366-6372.
10. Bates S. E., Lee J. S., Dickstein B., Spolyar M. and Fojo A. T. (1993) Differential modulation of P-glycoprotein transport by protein kinase inhibition. Biochemistry 32, 9156-9164.
11. Beck W. T. and Cirtain M. C. (1982) Continued expression of Vinca alkaloid resistance by CCRF-CEM cells after treatment with tunicamycin or pronase. Cancer Res. 209, 184-189.
12. Bellamy W. T. and Dalton W. S. (1994) Multidrug resistance in the laboratory and clinic. Adv. Clin. Chem. 31, 1-61.
13. Biedler J. L. and Riehm H. (1970) Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic and cytogenetic studies. Cancer Res. 30, 1174-1184.
14. Bourhis J., Bénard J., Hartmann O., Boccon-Gibod L., Lemerle J. and Riou G. (1989) Correlation of MDR1 gene expression with chemotherapy in neuroblastoma. J. Natl. Cancer Inst. 81, 1401-1405.
15. Burt R. K. and Thorgeirsson S. S. (1988) Coinduction of MDR-1 multidrug-resistance and cytochrome P-450 genes in rat liver by xenobiotics. J. Natl. Cancer Inst. 80, 1383-1386.
16. Burt R. K., Garfield S., Johnson K. and Thorgeirsson S. S. (1988) Transformation of rat liver epithelial cells with v-H-ras or v-raf causes expression of MDR-1, glutathione-S-transferase-P and increased resistance to cytotoxic chemicals.Carcinogenesis 9, 2329-2332.
17. Callaghan R. and Riordan J. R. (1993) Synthetic and natural opiates interact with P-glycoprotein in multidrug resistant cells. J. Biol. Chem. 268, 16059-16064.
18. Callen D. F., Baker E., Simmers R. N., Seshadri R. and Roninson I. B. (1987) Localization of the human multiple drug resistance gene, MDR1, to 7q21.1. Hum. Genet. 77, 142-144.
19. Campos L, Guyotat D., Archimbaud E., Calmar-Oriol P., Tsuruo T., Troncy J., Treille D. and Fioro D. (1992) Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood 79, 473-476.
20. Chambers T. C., Zheng B. and Kuo J. F. (1992) Regulation by phorbol ester and protein kinase C inhibitors and by a protein phosphatase inhibitor (okadaic acid) of P-glycoprotein phosphorylation and relationship to drug accumulation in multidrug-resistant human KB cell. Mol. Pharmacol. 41, 1008-1015.
21. Chan H. S. L., Thorner P. S., Haddad G. and Ling V. (1990) Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood. J. Clin. Oncol. 8, 689-704.
22. Chaudhary P. M. and Roninson I. B. (1991) Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66, 85-94.
23. Chaudhary P. M., Metchener E. B. and Roninson I. B. (1992) Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood 80, 2735-2739.
24. Chaudhary P. M. and Roninson I. B. (1992) Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists. Oncology Res. 4, 281-290.
25. Chaudhary P. M. and Roninson I. B. (1993) Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J. Natl. Cancer Inst. 85, 632-639.
26. Chen C. J., Chin J. E., Ueda K., Clark D. P., Pastan I., Gottesman M. M. and Roninson I.B. (1986) Internal duplication and homology with bacterial transport proteins in the mdr1(P-glycoprotein) gene from multidrug-resistant human cells. Cell 47, 381-389.
27. Chen C. J., Clark D., Ueda K., Pastan I., Gottesman M. M. and Roninson I. B. (1990) Genomic organisation of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins. J. Biol. Chem. 265, 506-514.
28. Chen G., Jaffrézou J. P., Fleming W. H., Duran G. E. and Sikic B. I. (1994) Prevalence of multidrug resistance related to activation of the mdr1 gene in human sarcoma mutants derived by single-step doxorubicin selection. Cancer Res. 54, 4980-4987.
29. Cheng A. L., Su I. J., Chen Y. C., Lee T. C. and Wang C. H. (1993) Expression of P-glycoprotein and glutathione S-transferase in recurrent lymphoma/The possible role of Epstein-Barr virus, immunophenotypes and other predisposing factors. J. Clin. Oncol. 11, 109-115.
30. Chin J. E., Soffir R., Noonan K. E., Choi K. and Roninson I. B. (1989) Structure and expression of the human MDR (P-glycoprotein) gene family. Mol. Cell. Biol. 9, 3808-3820.
31. Chin K. V., Chauchan S. S., Pastan I. and Gottesman M. M. (1990a) Regulation of mdr RNA levels in response to cytotoxic drugs in rodent cells. Cell Growth Differ. 1, 361-365.
32. Chin K. V., Tanaka S., Darlington G., Pastan I. and Gottesman M. M. (1990b) Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J. Biol. Chem. 265, 221-226.
33. Chin K. V., Ueda K., Pastan I. and Gottesman M. M. (1992) Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. Science 255, 459-462
34. Cole S. P. C., Bhardwaj G., Gerlach J. H., Mackie J. E., Grant C. E., Almquist K. C., Stewart A. J., Kurtz E. U., Duncan A. M. V. and Deeley R. G. (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258, 1650-1654.
35. Combates N. J., Rzepka R. W., Chen Y. N. P. and Cohen D. (1994) NF-IL6, a member of the C/EBP family of transcription factors, binds and transactivates the human MDR1 gene promoter. J. Biol. Chem. 269, 29715-29719.
36. Cordon-Cardo C., O'Brien J. P., Casals D., Rittman-Grauer L., Biedler J. L., Melamed M. R. and Bertino J. (1989) Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc. Natl. Acad. Sci. USA 86, 695-698.
37. Cornwell M. M., Safa A. R., Felsted R. L., Gottesman M. M. and Pastan I. (1986) Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150-to 170 kDa protein detected by photoaffinity labeling. Proc. Natl. Acad. Sci. USA 83, 3847-3850.
38. Cornwell M. M. and Smith D. E. (1993a) SP1 activates the MDR1 promoter through one of two distinct G-rich regions that modulate promoter activity. J. Biol. Chem. 268, 19505-19511.
39. Cornwell M. M. and Smith D. E. (1993b) A signal transduction pathway for activation of the mdr1 promoter involves the proto-oncogene c-raf kinase. J. Biol. Chem. 268, 15347-15350.
40. Croop J. M., Raymond M., Haber D., Devault A., Arceci R. J., Gros P. and Housman D. E. (1989) The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Mol. Cell. Biol., 9, 1346-1350.
41. Currier S. J., Kane S. E., Willingham M. C., Cardarelli C. O., Pastan I. and Gottesman M. M. (1992) Identification of residues in the first cytoplasmic loop of P-glycoprotem involved in the function of chimeric human MDR1-MDR2 transporters. J. Biol. Chem. 267, 25153-25159.
42. Cuvier C., Roblot-Treupel L., Chevillard S., Millot J. M., Manfait M., Bastian G., Couvreur P. and Poupon M. F. (1992) Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance. Biochem. Pharmacol. 44, 509-517.
43. Danö K. (1973) Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells. Biochim. Biophys. Acta 323, 466-483.
44. Devine S. E., Ling V. and Melera P. W. (1992) Amino acid substitution in the sixth transmembrane domain of P-glycoprotein alter multidrug resistance. Proc. Natl. Acad. Sci. USA 89, 4564-4568.
45. Drach D., Zhao S., Drach J. and Anoheeff M. (1995) Low incidence of MDR1 expression in acute promyelocytic leukaemia. Br. J. Haematol. 90, 369-374.
46. Drenou B., Fardel O., Amiot L. and Fauchet R. (1993) Detection of P-glycoprotein activity in normal and leukemic CD34 positive cells. Leukemia Res. 17, 1031-1035.
47. Efferth T. and Volm M. (1993) Modulation of P-glycoprotein-mediated MDR by monoclonal antibodies, immunotoxins or antisense oligodeoxy nucleotides in kidney carcinoma and normal kidney cells. Oncology 50, 303-308.
48. Fardel O., Ratanasavanh D., Loyer P., Ketterer B. and Guillouzo A. (1992) Overexpression of the multidrug resistance gene product in adult rat hepatocytes during primary cultures. Eur. J. Biochem. 205, 847-852.
49. Fardel O., Morel F. and Guillouzo A. (1993a) P-glycoprotein expression in human, mouse, hamster and rat hepatocytes in primary cultures. Carcinogenesis 14, 781-783.
50. Fardel O., Lecureur V. and Guillouzo A. (1993b) Regulation by dexamethasone of P-glycoprotein expression in cultured rat hepatocytes. FEBS Lett., 327, 189-193.
51. Fardel O., Loyer P., Lecureur V., Glaise D. and Guillouzo A. (1994) Constitutive expression of functional P-glycoprotein in rat hepatoma cells. Eur. J. Biochem. 219, 521-528.
52. Fardel O., Lecureur V., Loyer P. and Guillouzo A. (1995) Rifampicin enhances anti-cancer drug accumulation and activity in multidrug-resistant cells. Biochem. Pharmacol. 49, 1255-1260.
53. Fine R. L., Patel J. and Chabner B. A. (1988) Phorbol esters induce multidrug resistance in human breast cancer cells. Proc. Natl. Acad. Sci. USA 85, 582-586.
54. Fojo A., Ueda K., Slamon D. J., Poplack D., Gottesman M. M. and Pastan I. (1987) Expression of a multidrug-resistance gene in human tumors and tissues. Proc. Natl. Acad. Sci. USA 84, 265-269.
55. Foote S. J., Thompson J. K., Cowman A. F. and Kemp D. J. (1989) Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum. Cell 57, 921-930.
56. Ford J. M. and Hait W. N. (1990) Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev. 42, 155-199.
57. Gant T. W., Silverman J. A., Bisgaard H. C., Burt R. K., Marino P. and Thorgeirsson S. S. (1991) Regulation of 2-acetylaminofluorene- and 3-methylcholanthrene-mediated induction of multidrug resistance and cytochrome P450IA gene family expression in primary hepatocyte cultures and rat liver. Mol. Carcinog. 4, 499-509.
58. Gant T. W., Silverman J. A. and Thorgeirsson S. S. (1992) Regulation of P-glycoprotein expression in hepatocyte cultures and liver cell lines by a trans-acting transcriptional repressor. Nucleic Acids Res. 20, 2841-2846.
59. Georges E., Bradley G., Gariepy J. and Ling V. (1990) Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies. Proc. Natl. Acad. Sci. USA 87, 152-156.
60. Gerlach J. H., Endicott J. A., Juranka P. F., Henderson G., Sarangi F., Deuchars K. L. and Ling V. (1986) Homology between P-glycoprotein and a bacterial haemolysin transport protein suggest a model for multidrug resistance. Nature 324, 485-489.
61. Goasguen J. E., Dossot J-M., Fardel O., Le Mée F., Le Gall E., Le Blay R., Le Prisé P. Y. and Fauchet R. (1993) Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications. Blood 81, 2394-2398.
62. Goldsmith M. E., Madden M. J., Morrow C. S. and Cowan K. H. (1993) A Y-box consensus is required for basal expression of the human multidrug resistance (mdr1) gene. J. Biol. Chem. 268, 5856-5860.
63. Goldstein L. J., Galski H., Fojo A., Willingham M., Lai S. H., Gazdar A., Pirker R., Green A., Crist W., Brodeur G. M., Lieber M., Cossma J., Gottesman M. M. and Pastan I. (1989) Expression of a multidrug resistance gene in human cancer. J. Natl. Cancer Inst. 81, 116-124.
64. Gottesman M. M. and Pastan I. (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann. Rev. Biochem. 62, 385-427.
65. Grant C. E., Valdimarsson G., Hipfner D. R., Almquist K. C., Cole S. P. C. and Deeley R. G. (1994) Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res. 54, 357-360.
66. Grogan T. M., Spier C. M., Salmon S. E., Matner M., Rybski J., Weinstein R., Scheper R. J. and Dalston W. S. (1993) P-glycoprotein expression in human plasma cell myeloma: Correlation with prior chemotherapy. Blood 81, 490-495.
67. Gros P., Ben Neriah Y., Croop J. M. and Housman D. E. (1986) Isolation and expression of a cDNA (mdr) that confers multidrug resistance. Nature 323, 728-731.
68. Gros P., Dhir R., Croop J. and Talbot F. A. (1991) A single aminoacid substitution strongly modulates the activity and substratee specificity of the mouse mdr1 and mdr3 drug efflux pumps. Proc. Natl. Acad. Sci. USA 88, 7289-7293.
69. Grulois I., Fardel O., Drenou B., Lamy T., Le Prisé P. Y. and Fauchet R. (1995) Multidrug resistance in B-cell chronic lymphocytic leukemia. Acta Haematol. 94, 78-83.
70. Hait W. N. and Aftab D. T. (1992) Rational design and preclinical pharmacology of drugs for reversing multidrug resistance. Biochem. Pharmacol. 43, 103-107.
71. Hamada H. and Tsuruo T. (1986) Functional role for the 170-to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc. Natl. Acad. Sci. USA 83, 7785-7789.
72. Hamada H., Hagiwara K. I., Nakajima T. and Tsuruo T. (1987) Phosphorylation of the 170,000 to 180,000 glycoprotein specific to multidrug-resistant tumor cells: Effects of verapamil, trifluoperazine and phorbol esters. Cancer Res. 47, 2860-2865.
73. Herweijer H., Sonneveld P., Baas F. and Nooter K. (1990) Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine. J. Natl. Cancer Inst. 82, 1133-1140.
74. Herzog C. E., Tsokos S. E., Bates S. E. and Fojo A. T. (1994) Increased mdr1/P-glycoprotein expression after treatment of human colon carcinoma cells with P-glycoprotein antagonists. J. Biol. Chem. 268, 2946-2952.
75. Higgins C. F. and Gottesman M. M. (1992) Is the multidrug transporter a flippase? Trends Biochem. Sci. 17, 18-21.
76. Holmes J. A. and West R. R. (1994) The effect of MDR-1 gene expression on outcome in acute myeloblastic leukemia. Br. J. Cancer 69, 382-384.
77. Huang C., Wu M., Xu G., Li D., Cheng H., Tu Z., Jiang H. and Gu J. (1992) Overexpression of the MDR1 gene and P-glycoprotein in human hepatocellular carcinoma. J. Natl. Cancer Inst. 84, 262-264.
78. Ikeguchi M., Teeter L. D., Eckersberg T., Ganapathi R. and Kuo T. M. (1991) Structural and functional analyses of the promoter of the murine multidrug resistance gene mdr3/mdr1a reveal a negative element containing the AP-1 binding site. DNA Cell Biol. 10, 639-649.
79. Ino T., Miyazaki H., Isogar M., Nomura T., Tsuzuki M., Tsuruo T., Ezaki K. and Hirano M. (1994) Expression of P glycoprotein in de novo acute myclogenous leukemia at initial diagnosis: results of molecular and functional assays and correlation with treatment outcome. Leukemia 8, 1492-1497.
80. Jachez B., Nordmann R. and Loor F. (1993) Restoration of taxol sensitivity of multidrug-resistant cells by the cyclosporine SDZ PSC 833 and the cyclopeptide SDZ 280-446. J. Natl. Cancer Inst. 85, 478-483.
81. Jancis E. M., Carbone R., Loechner K. J. and Dannies P. S. (1993) Estradiol induction of rhodamine 123 efflux and the multidrug resistance pump in rat pituitary cells. Mol. Pharmacol. 43, 51-56.
82. Joly B., Fardel O., Cecchelli R., Chesné C., Puozzo C. and Guillouzo A. (1995) Selective drug transport and P-glycoprotein activity in an in vitro blood-brain barrier model. Tox. In Vitro 9, 357-364.
83. Juliano R. L. and Ling V. (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta 455, 155-162.
84. Kanamaru H., Kakehi Y., Yoshida O., Nakanishi S., Pastan I. and Gottesman M.M. (1989) MDR1 RNA levels in human renal cell carcinomas: correlation with grade and prediction of doxorubicin resistance by quinidine in tumor explants. J. Natl. Cancer Inst. 82, 1679-1683.
85. Kessel D. and Bosmann H. B. (1970) On the characteristics of actinomycin D resistance in L5178Y cells. Cancer Res. 30, 2695-2701.
86. Kiehntopf M., Brach M. A., Licht T., Petschauer S., Karawajew L., Kirschning C. and Herrmann F. (1994) Ribozyme-mediated cleavage of the MDR-1 transcript restores chemosensitivity in previously resistant cancer cells. EMBO J. 13, 4645-4652.
87. Kioka N., Yamano Y., Komano T. and Ueda K. (1992) Heat-shock responsive elements in the induction of the multidrug resistance gene (MDR1). FEBS Lett. 301, 37-40.
88. Kramer R., Weber T. K., Morse B., Arceci R., Staniunas R., Steele G. and Summerhayes I. C. (1993) Constitutive expression of multidrug resistance in human colorectal tumours and cell lines. Br. J. Cancer 67, 959-968.
89. Kobayashi Y., Yamashiro T., Nagatake H., Yamamoto T., Watanabe N., Tanaka H., Shigenobu K. and Tsuruo T. (1994) Expression and function of multidrug resistance P-glycoprotein in a cultured natural killer cell-rich population revealed by MRK 16 monoclonal antibody and AHC-52. Biochem. Pharmacol. 48, 1641-1646.
90. Kohno K., Sato S., Takano H., Matsuo K. and Kuwano M. (1989) The direct activation of human multidrug resistance gene (MDR1) by anticancer agents. Biochem. Biophys. Res. Commun. 165, 1415-1421.
91. Kuwazuru Y., Yoshimura A., Hanada S., Ichikawa M., Saito T., Uozumi K., Utsunomiya A., Arima T. and Akiyama S.-I. (1990) Expression of the multidrug transporter, P-glycoprotein, in chronic myelogenous leukaemia cells in blast crisis. Br. J. Haematol. 74, 24-29.
92. Lai S. L., Goldstein L. J., Gottesman M. M., Pastan I., Tsai C. M., Johnson B. E., Mulshine J. L., Ihde D. C., Kayser K. and Gazdar A. F. (1989) MDR1 gene expression in lung cancer. J. Natl. Cancer Inst. 81, 1144-1150.
93. Lamy T., Drenou B., Grulois I., Fardel O., Jacquelinet C., Goasguen J. E., Dauriac C., Amiot L., Bernard M., Fauchet R. and Le Prisé P. Y. (1995) Multidrug resistance (MDR activity) in acute leukemia determined by rhodamine 123 efflux assay. Leukemia 9, 1549-1555.
94. Lecureur V., Fardel O. and Guillouzo A. (1994) The antiprogestatin drug RU 486 potentiates doxorubicin cytotoxicity in multidrug resistant cells through inhibition of P-glycoprotein function. FEBS Lett. 355, 187-191.
95. Levêque D. and Jehl F. (1995) P-glycoprotein and pharmacokinetics. Anticancer Res. 15, 331-336.
96. List A. F., Spier C. M., Cline A., Doll D. C., Garewal H., Morgan R. and Sandberg A. A. (1991) Expression of the multidrug resistance gene product (P-glycoprotein) in myelodysplasia is associated with a stem cell phenotype. Br. J. Haematol., 78, 28-34.
97. List A. F., Spier C., Greer J., Wolff S., Hutter J., Dorr R., Salmon S., Futscher B., Baier M. and Dalton W. (1993) Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia. J. Clin. Oncol. 11, 1652-1660.
98. Marie J. P., Zittoun R. and Sikic B. I. (1991) Multidrug resistance (mdr 1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity. Blood 78, 586-592.
99. Marino P. A., Gottesman M. M. and Pastan I. (1990) Regulation of the multidrug resistance gene in regenerating rat liver. Cell Growth and Differ. 1, 57-62.
100. McGrath J. P. and Varshavsky A. (1989) The yeast STE6 encodes a homologue of the mammalian multidrug resistance P-glycoprotein. Nature 340, 400-404.
101. Mellado W. and Horwitz S. B. (1987) Phosphorylation of the multidrug resistance associated glycoprotein. Biochemistry 26, 6900-6904.
102. Merkel D. E., Fuqua S. A., Tandon A. K., Hill S. M., Buzdar A. U. and McGuire W. L. (1989) Electrophoretic analysis of 248 clinical breast cancer specimens for P-glycoprotein overexpression or gene amplification. J. Clin. Oncol. 7, 1129-1136.
103. Metchener E. B. and Roninson I. B. (1992) Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody. Proc. Natl. Acad. Sci. USA 89, 5824-5828.
104. Meyers M. B., Spengler B. A., Chang T. D., Melera P. W. and Biedler J. L. (1985) Gene amplification-associated cytogenetic aberrations and protein changes in vincristine-resistance cells. J. Cell Biol. 100, 588-597.
105. Mickley A. L., Bates S. S., Richert N. D., Currier S., Tanaka S., Foss F., Rosen N. and Fojo A. T. (1989) Modulation of the expression of a multidrug resistance gene (mdr-1/P-glycoprotein) by differentiating agents. J. Biol. Chem. 264, 18031-18040.
106. Morrow C. S., Nakagawa M., Goldsmith M. E., Madden M. J. and Cowan K. H. (1994) Reversible transcriptional activation of mdr1 by sodium butyrate treatment of human colon cancer cells. J. Biol. Chem. 269, 10739-10746.
107. Moscow J. A., Fairchild C. R., Madden M. J., Ramson D. T., Wieand H. S., O'Brien E., Poplack D. G., Cossman J., Myers C. E. and Cowan K. H. (1989) Expression of anionic glutathione S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res. 48, 1422-1428.
108. Muller C., Goubin F., Fernandis E., Cornil-Schwartz I., Bailly J. D., Bordier C., Bernard J. and Laurent G. (1995) Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug resistant leukemic cells. Mol. Pharmacol. 47, 51-56.
109. Müller M., Meijer C., Zaman G. J. R., Borst P., Scheper R. J., Mulder N., De Vries E. G. E. and Jansen P. L. M. (1994) Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc. Natl. Acad. Sci. USA 91, 13033-13037.
110. Neyfakh A. A. (1988) Use of fluorescent dyes as molecular probes for the study of multidrug resistance. Exp. Cell Res. 174, 168-176.
111. Nooter K. and Herweijer H. (1991) Multidrug resistance (mdr) in human cancer. Br. J. Cancer 63, 663-669.
112. Pennock G. D., Dalton W. S., Roeske W. R., Appleton C. P., Mosley K., Plezia P., Miller T. P. and Salmon S. E. (1991) Systemic toxic effects associated with high-dose verapamil infusion and chemotherapy administration. J. Natl. Cancer Inst. 83, 105-110.
113. Petrini M., Di Simone D., Favati A., Mattii L., Valentini P. and Grassi B. (1995) GST-pi and P-170 co-expression in multiple myeloma. Br. J. Haematol. 90, 393-397.
114. Piekarz R. L., Cohen D. and Horwitz S. B. (1993) Progesterone regulates the murine multidrug resistance mdr1b gene. J. Biol. Chem. 268, 7613-7616.
115. Pirker R., Wallner J., Geissler K., Linkesch W., Haas O. A., Bettelheim P., Hopfner M., Scherrer R., Valent P., Havelec L., Ludwig H. and Lechner K. (1991) MDR1 gene expression and treatment outcome in acute myeloid leukemia. J. Natl. Cancer Inst. 83, 708-712.
116. Raymond M. and Gros P. (1990) Cell-specific activity of cis-acting elements in the promoter of the mouse multidrug resistance gene mdr1. Mol. Cell. Biol. 11, 6036-6040.
117. Raymond M., Rose E., Housman D. E. and Gros P. (1990) Physical mapping amplification and overexpression of the mouse mdr gene family in multidrug-resistant cells. Mol. Cell. Biol. 10, 1642-1651.
118. Riordan J. R., Deuchars K., Kartner N., Alon N., Trent J. and Ling V. (1985) Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines. Nature 316, 817-819.
119. Riordan J. R., Rommens J. M., Kerem B., Alon N., Rozmahel R., Grzelczak Z., Zielenski J. Lok S., Plavsic N., Chou J. L., Drumm M. L., Iannuzzi M. C., Collins F. S. and Tsui L. C. (1989). Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245, 1066-1073.
120. Rochlitz C. F., Lobreck H., Peter S., Reuter J., Mohr B., De Kant E., Huhn D. and Herrmann R. (1992) Multiple drug resistance gene expression in human renal cell cancer is associated with the histologic subtype. Cancer 69, 2993-2998.
121. Roepe P. D., Wei L. Y., Cruz J. and Carlson D. (1993) Lower electrical membrane potential and altered pHi homeostasis in multidrug-resistant (MDR) cells: Further characterization of a series of MDR cell lines expressing different levels of P-glycoprotein. Biochemistry 32, 11042-11056.
122. Roninson I. B. (1992) The role of the MDR1 (P-glycoprotein) gene in multidrug resistance in vitro and in vivo. Biochem. Pharmacol. 43, 95-102.
123. Roninson I. B., Abelson H., Housman D. E., Howell N. and Varshavsky A. (1984) Amplification of specific DNA sequences correlates with multidrug resistance in Chinese hamster cells. Nature 309, 626-628.
124. Roninson I. B., Chin J. E., Choi K., Gros P., Housman D. E., Fojo A., Shen D., Gottesman M. M. and Pastan I. (1986) Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc. Natl. Acad. Sci. USA 83, 337-341.
125. Russel A. L., Henderson C. J., Smith G. and Wolf C. R. (1994) Suppression of multi-drug resistance gene expression in the mouse liver by 1,4-bis[2,(3,5-dichloropyridyloxy)]benzene. Int. J. Cancer 58, 550-554.
126. Safa A. R., Glover C. J., Sewel J. L., Meyers M. B., Biedler J. L. and Felsted R. L. (1987) Identification of the multidrug-resistance related membrane glycoprotein as an acceptor for calcium channel blockers. J. Biol. Chem. 262, 7884-7888.
127. Scheper R. J., Bulte J. W. M., Brakkee J. G. P., Quak J. J., Van der Schoot E., Balm A. J. M., Meijer C. J. L. M., Broxterman H. J., Kuiper C. M., Lankelma J. and Pinedo H. M. (1988) Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multi-drug resistance. Int. J. Cancer 42, 389-394.
128. Schinkel A. H., Roelofs E. M. and Borst P. (1991) Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies. Cancer Res. 51, 2628-2635.
129. Schneider J., Rak M., Efferth T., Kaufmann M., Mattern J. and Volm M. (1989) P-glycoprotein expression in treated and untreated human breast cancer. Br. J. Cancer 60, 815-818.
130. Schrenk D., Gant T. W., Preisegger K. H., Silverman J. A., Marino P. A. and Thorgeirsson S. S. (1993) Induction of multidrug resistance gene expression during cholestasis in rats and nonhuman primates. Hepatology 17, 854-860.
131. Schrenk D., Gant T. W., Michalke A., Orzechowski A., Silverman J. A., Battula N. and Thorgeirsson S. S. (1994) Metabolic activation of 2-acetylaminofluorene is required for induction of multidrug resistance gene expression in rat liver cells. Carcinogenesis 15, 2541-2546.
132. Shapiro A. B. and Ling V. (1995) Reconstitution of drug transport by purified P-glycoprotein. J. Biol. Chem. 270, 16167-16175.
133. Sharma R. C., Inoue S., Roitelman J., Schimke R. T. and Simoni R. D. (1992) Peptide transport by the multidrug resistance pump. J. Biol. Chem. 267, 5731-5734.
134. Sikic B. I. (1993) Modulation of multidrug resistance: at the threshold. J. Clin. Oncol. 11, 1629-1635.
135. Silverman J. A. and Hill B. A. (1995) Characterization of the basal and carcinogen regulatory elements of the rat mdr1b promoter. Mol. Carcinog. 13, 50-59.
136. Smit J. J. M., Schinkel A. H., Oude Elferink R., Groen A. K., Wagenaar E., Van Deemter L., Mol C. A., Ottenhoff R., Van der Lugt N. M., Van Room M., Van der Valk M. A., Offerhaus G. J., Berns A. J. and Borst P. (1993) Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75, 451-462.
137. Tanigawara Y., Okamura N., Hirai M., Yasuhara M., Ueda K., Kioka N., Komano T. and Hori R. (1992) Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line LLC-PK1. J. Pharmacol. Exp. Ther., 263, 840-845.
138. te Boekhorst A. W., de Leeuw K., Schoester M., Wittebol S., Nooter K., Hagemeijer A., Löwenberg B. and Sonneveld P. (1993) Predominance of functional multidrug resistance (MDR-1) phenotype in CD34+ acute myeloid leukemia cells. Blood 82, 3157-3162.
139. Teeter L. D., Becker F. F., Chisari F. V., Li D. and Kuo M. T. (1990) Overexpression of the multidrug resistance gene mdr3 in spontaneous and chemically induced mouse hepatocellular carcinomas. Mol. Cell. Biol. 10, 5728-5735.
140. Teeter L. D., Eckersberg T., Tsai Y. and Kuo M. T. (1991) Analysis of the Chinese hamster P-glycoprotein/multidrug resistance gene pgp1 reveals that the AP-1 site is essential for full promoter activity. Cell Growth Differ. 2, 429-437.
141. Thiebaut F., Tsuruo T., Hamada H., Gottesman M. M., Pastan I. and Willingham M. C. (1987) Cellular localisation of the multidrug resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. USA 84, 7735-7738.
142. Thiebaut F., Tsuruo T., Hamada H., Gottesman M. M., Pastan I. and Willingham M. M. (1989) Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein p170: Evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein. J. Histochem. Cytochem. 37, 159-164.
143. Thierry A. R., Vigé D., Coughlin S. S., Belli J. A., Dritschillo A. and Rahman A. (1993) Modulation of doxorubicin resistance in multidrug-resistant cells by liposomes. FASEB J. 7, 572-579.
144. Trowsdale J., Hanson I., Mockridge I., Beck S., Townsend A. and Kelly A. (1990) Sequences encoded in the class II region of the MHC related to the "ABC" superfamily of transporters. Nature 348, 741-744.
145. Tsuruo T., Iida H., Tsukagoshi S. and Sakurai Y. (1981) Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res. 41, 1967-1972.
146. Ueda K., Cornwell M. M., Gottesman M. M., Pastan I., Roninson I. B., Ling V. and Riordan J. R. (1986) The mdr1 gene responsible for multidrug resistance codes for P-glycoprotein. Biochim. Biophys. Res. Commun. 141, 956-962.
147. Ueda K., Cardarelli C., Gottesman M. M. and Pastan I. (1987a) Expression of a full length cDNA for the human mdr1 gene confers resistance to colchicine, doxorubicin and vinblastine. Proc. Natl. Acad. Sci USA 84, 3004-3008.
148. Ueda K., Pastan I. and Gottesman M. M. (1987b) Isolation and sequence of the promoter region of the human multidrug-resistance (P-glycoprotein) gene. J. Biol. Chem. 262, 17432-17436.
149. Valverde M. A., Diaz M., Sepulveda F. V., Gill D. R., Hyde S. C. and Higgins C. F. (1992) Volume-regulated chloride channels associated with the human multidrug resistance P-glycoprotein. Nature 355, 830-833.
150. Van Kalken C. K., Broxterman H. J., Pinedo H. M., Feller N., Lankelma J. and Giaccone G. (1993) Cortisol is transported by the multidrug resistance gene product P-glycoprotein. Br. J. Cancer 67, 284-289.
151. Vendrik C. P. J., Bergers J. J., De Jong W. H. and Steerenberg P. A. (1992) Resistance to cytostatic drugs at the cellular level. Cancer Chemother. Pharmacol. 29, 413-429.
152. Wei L. Y. and Roepe P. D. (1994) Low external pH and osmotic shock increase the expression of human MDR protein. Biochemistry 33, 7229-7238.
153. Yeh G. C., Lopaczynska J., Poore C. M. and Phang J. M. (1992) A new functional role for P-glycoprotein: Efflux pump for benzo(a)pyrene in human breast cancer MCF-7 cells. Cancer Res. 52, 6692-6695.
154. Yuen A. R. and Sikic B. I. (1994) Multidrug resistance in lymphomas. J. Clin. Oncol. 12, 2453-2459.
155. Yusa K. and Tsuruo T. (1989) Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells. Cancer Res. 49, 5002-5006.
156. Zhao J. Y., Ikeguchi M., Eckersberg T. and Kuo M. T. (1993) Modulation of multidrug resistance gene expression by dexamethasone in cultured hepatoma cells. Endocrinology 133, 521-528.
157. Zhou D. C., Zittoun R. and Marie J. P. (1995) Expression of multidrug resistance-associated protein (MRP) and multidrug resistance (MDR1) genes in acute myeloid leukemia. Leukemia 9, 1661-1666.